Evidence map›Paper›PMID 32874442›Full record

ArticleCaspian journal of internal medicine2020

Does an antimicrobial stewardship program for Carbapenem use reduce Costs? An observation in Tehran, Iran.

Mahboubeh Hajiabdolbaghi, Jalil Makarem, Mohammadreza Salehi, Seyed Ali Dehghan Manshadi, Esmaeil Mohammadnejad, Hossein Mazaherpoor, Arash Seifi

Open access · greenAbstract read
In one paragraph

Article in Caspian journal of internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Burden and Economic Impact of Antimicrobial Resistance inThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mahboubeh HajiabdolbaghiDepartment of Infectious Diseases, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Jalil MakaremDepartment of Anesthesiology and Critical Care, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadreza SalehiDepartment of Infectious Diseases, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Ali Dehghan ManshadiDepartment of Infectious Diseases, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Esmaeil MohammadnejadDepartment of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
Hossein MazaherpoorDepartment of Infectious Diseases, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Arash SeifiDepartment of Infectious Diseases, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInappropriate administering of antimicrobials has led to increased antibiotic resistance as well as burden of infectious diseases. Antibiotic stewardship programs (ASPs) help prevent resistance through improved utilization of antimicrobial agents while potentially decrease costs of treatment.

methodsWe reviewed 186 infectious disease (ID) consultations from two internal disease wards in a tertiary center where ID specialists were asked to confirm carbapenem use in patients within 48 hours of initiation. The records were reviewed in terms of age, gender, and final decision about carbapenem use. The crude mortality rates during the 5-month period of the study (May to September 2016) as well as hospital spendings were compared with the same time of the year before the implementation of the ASP.

resultsOf the 186 consultations conducted by the ID specialists, 28 (15%) consultations led to antibiotic change, 46 (25%) led to discontinuation, while 112 (60%) carbapenems were continued. An estimate of 14,000 € was saved based on the annual hospital costs during the 5-month period of the study. Although antimicrobial resistance patterns could not be evaluated, the crude mortality rate in the two IM wards was calculated to be 2.6% with no significant change compared to previous year (CMR: 2.9%).

conclusionBased on findings of the present study, ASPs for carbapenems (as wide-spectrum agents) can lower costs with no increased mortality rates in a tertiary center located in a middle-income country.

Indexed as

Anti-infective agentsAntimicrobial stewardshipCarbapenemDrug resistanceIran

Identifiers

PMID32874442
PMCPMC7442459
OpenAlexW3034229330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.